Comparison of different cellular models measuring in vitro the whole human serum cholesterol efflux capacity

European Journal of Clinical Investigation

Volumn 36, Issue 8, 2006, Pages 552-559

  Mweva, S ^a   Paul, J L ^a,b   Cambillau, M ^a   Goudouneche, D ^b   Beaune, P ^a   Simon, A ^c   Fournier, N ^a,b  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c HÔPITAL BROUSSAIS   (France)

Author keywords

ATP binding cassette transporter 1; Cholesterol efflux; Fu5AH rat hepatoma cells; J774 mouse macrophages; Pre HDL; Scavenger receptor BI

Indexed keywords

ABC TRANSPORTER A1; CYCLIC AMP; HIGH DENSITY LIPOPROTEIN; PHOSPHOLIPID; SCAVENGER RECEPTOR BI;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; HEPATOMA CELL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CELLS, CULTURED; CHOLESTEROL; CYCLIC AMP; DYSLIPIDEMIAS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; LIPIDS; LIPOPROTEINS, HDL; LIVER NEOPLASMS, EXPERIMENTAL; MACROPHAGES; MALE; MICE; MODELS, BIOLOGICAL; RATS; SCAVENGER RECEPTORS, CLASS B;

EID: 33746174158     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2006.01673.x     Document Type: Article

References (37)

1. Barter PJ, Rye KA. High density lipoproteins and coronary heart disease. Atherosclerosis 1996;121:1-12.
2. von Eckardstein A, Nofer JR, Assmann G. High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 2001;21:13-27.
3. Rothblat GH, de la Llera-Moya M, Atger V, Kellner-Weibel G, Williams DL, Phillips MC. Cell cholesterol efflux: integration of old and new observations provides new insights. J Lipid Res 1999;40:781-96.
4. Rothblat GH, de la Llera-Moya M, Favari E, Yancey PG, Kellner-Weibel G. Cellular cholesterol flux studies: methodological considerations. Atherosclerosis 2002;163:1-8.
5. Yancey PG, Bortnick AE, Kellner-Weibel G, de la Llera Moya M, Phillips MC, Rothblat GH. Importance of different pathways of cellular cholesterol efflux. Arterioscler Thromb Vasc Biol 2003;23:712-9.
6. Johnson WJ, Mahlberg FH, Rothblat G, Phillips MC. Cholesterol transport between cells and high-density lipoproteins. Biochim Biophys Acta 1991;1085:273-98.
7. Stangl H, Cao G, Wyne K, Hobbs HH. Scavenger receptor, class B, type I-dependent stimulation of cholesterol esterification by high density lipoproteins, low-density lipoproteins, and nonlipoprotein cholesterol. J Biol Chem 1998;273:31002-8.
8. Williams DL, Connelly MA, Temel RE, Swarnakar S, Phillips MC, de la Llera Moya M et al. Scavenger receptor BI and cholesterol trafficking. Curr Opin Lipidol 1999;10:329-39.
9. Oram JF. ATP-binding cassette transporter A1 and cholesterol trafficking. Curr Opin Lipidol 2002;13:373-81.
10. Wang N, Tall AR. Regulation and mechanisms of ATP-binding cassette transporter A1-mediated cellular cholesterol efflux. Arterioscler Thromb Vasc Biol 2003;23:1178-84.
11. Wang N, Lan D, Chen W, Matsuura F, Tall AR. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci U S A 2004;101:9774-9.
12. Nakamura K, Kennedy MA, Baldan A, Bojanic DD, Lyons K, Edwards PA. Expression and regulation of multiple murine ATP-binding cassette transporter G1 mRNAs/isoforms that stimulate cellular cholesterol efflux to high density lipoprotein. J Biol Chem 2004;279:45980-9.
13. Ji Y, Jian B, Wang N, Sun Y, Moya ML, Phillips MC et al. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem 1997;272:20982-5.
14. Bortnick AE, Rothblat GH, Stoudt G, Hoppe KL, Royer LJ, McNeish J et al. The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J Biol Chem 2000;275:28634-10.
15. Zanotti I, Favari E, Sposito AC, Rothblat GH, Bernini F. Pitavastatin increases ABCA1-mediated lipid efflux from Fu5AH rat hepatoma cells. Biochem Biophys Res Commun 2004;321:670-4.
16. Fournier N, Atger V, Cogny A, Vedie B, Giral P, Simon A et al. Analysis of the relationship between triglyceridaemia and HDL-phospholipid concentrations: consequences on the efflux capacity of serum in the Fu5AH system. Atherosclerosis 2001;157:315-23.
17. Fournier N, Francone O, Rothblat G, Goudouneche D, Cambillau M, Kellner-Weibel G et al. Enhanced efflux of cholesterol from ABCA1-expressing macrophages to serum from type IV hypertriglyceridaemic subjects. Atherosclerosis 2003;171:287-93.
18. Favari E, Lee M, Calabresi L, Franceschini G, Zimetti F, Bernini F et al. Depletion of pre-beta-high-density lipoprotein by human chymase impairs ATP-binding cassette transporter A1-butnot scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein. J Biol Chem 2004;279:9930-6.
19. Smith JD, Miyata M, Ginsberg M, Grigaux C, Shmookler E, Plump AS. Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors. J Biol Chem 1996;271:30647-55.
20. Sakr SW, Williams DL, Stoudt GW, Phillips MC, Rothblat GH. Induction of cellular cholesterol efflux to lipid-free apolipoprotein A-I by cAMP. Biochim Biophys Acta 1999;1438:85-98.
21. Oram JF, Lawn RM, Garvin MR, Wade DP. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J Biol Chem 2000;275:34508-11.
22. Fournier N, Atger V, Paul JL, Sturm M, Duverger N, Rothblat GH et al. Human ApoA-IV over-expression in transgenic mice induces cAMP-stimulated cholesterol efflux from J774 macrophages to whole serum. Arterioscler Thromb Vasc Biol 2000;20:1283-92.
23. Fournier N, Cogny A, Atger V, Pastier D, Goudouneche D, Nicoletti A et al. Opposite effects of plasma from human apolipoprotein A-II transgenic mice on cholesterol efflux from J774 macrophages and Fu5AH hepatoma cells. Arterioscler Thromb Vasc Biol 2002;22:638-43.
24. Beulens JW, Sierksma A, van Tol A, Fournier N, van Gent T, Paul JL et al. Moderate alcohol consumption increases cholesterol efflux mediated by ABCA1. J Lipid Res 2004;45:1716-23.
25. Yancey PG, Asztalos BF, Stettler N, Piccoli D, Williams DL, Connelly MA et al. SR-BI- and ABCA1-mediated cholesterol efflux to serum from patients with Alagille syndrome. J Lipid Res 2004;45:1724-32.
26. Castelli WP. Lipids, risk factors and ischaemic heart disease. Atherosclerosis 1996;124 (Suppl.):S1-9.
27. Gotto AM Jr. Rationale for treatment. Am J Med 1991;91:31S-6S.
28. Asztalos BF, Roheim PS, Milani RL, Lefevre M, McNamara JR, Horvath KV et al. Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 2000;20:2670-6.
29. de la Llera Moya M, Atger V, Paul JL, Fournier N, Moatti N, Giral P et al. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer. Arterioscler Thromb 1994;14:1056-65.
30. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
31. Atger V, Malon D, Bertiere MC, N'Diaye F, Girard-Globa A. Cholesterol distribution between high-density lipoprotein subfractions HDL2 and HDL3 determined in serum by discontinuous gradient gel electrophoresis. Clin Chem 1991;37:1149-52.
32. Asztalos BF, de la Llera-Moya M, Dallal GE, Horvath KV, Schaefer EJ, Rothblat GH. Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux. J Lipid Res 2005;46:2246-53.
33. Fournier N, de la Llera Moya M, Burkey BF, Swaney JB, Paterniti J Jr, Moatti N et al. Role of HDL phospholipid in efflux of cell cholesterol to whole serum: studies with human apoA-I transgenic rats. J Lipid Res 1996;37:1704-11.
34. Fournier N, Paul JL, Atger V, Cogny A, Soni T, de la Llera Moya M et al. HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum. Arterioscler Thromb Vasc Biol 1997;17:2685-91.
35. Dullaart RP, van Tol A. Twenty-four hour insulin infusion impairs the ability of plasma from healthy subjects and Type 2 diabetic patients to promote cellular cholesterol efflux. Atherosclerosis 2001;157:49-56.
36. Duong M, Collins HL, Jin W, Zanotti I, Favari E, Rothblat GH. Relative contributions of ABCA1 and SR-BI to cholesterol efflux to serum from fibroblasts and macrophages. Arterioscler Thromb Vasc Biol 2006;26:541-7.
37. Zimetti FK, Weibel G, Duong MN, Rothblat GH. Measurement of cholesterol bidirectional flux between cells and lipoproteins. J Lipid Res 2006;47:605-13.